Scope of the Report
This report provides an in-depth analysis of the global vaccine market by value, by disease, by type, by patient type, by region, etc. The report provides a regional analysis of the vaccine market, including the following regions: North America (the US & Rest of North America), Europe, Asia Pacific (China, Japan, India & Rest of Asia Pacific), Latin America and the Middle East and Africa. The report also provides a detailed analysis of the COVID-19 impact on the vaccine market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global vaccine market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global vaccine market is highly dominated with few major market players operating worldwide. The manufacturers of vaccines produce different types of vaccines for different diseases and for the patients of different age group. Further, key players of the vaccine market are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur), and Pfizer Inc. are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Coverage
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Sanofi S.A. (Sanofi Pasteur)
- Pfizer Inc.
Table of Contents
1. Executive Summary
Samples
LOADING...
Executive Summary
Vaccines are substances that inject a weakened form of the disease into a person’s body, to stimulate the production of antibodies and to provide immunity against infectious diseases. While drugs are administered to patients to treat medical problems, vaccines are administered to healthy children or adults to prevent infectious diseases. Vaccines can be injected through a needle; taken by mouth; and inhaled through the nose. A vaccine is considered to be very important, as it protects children from serious complications of preventable diseases. Vaccines are also safe and effective, as it is carefully reviewed by the scientists, doctors and researchers in different phases and trials. Vaccines are also proved beneficial in protecting future generations because they reduce or may have eliminated the impact of many diseases that killed people just a few generations ago.
There are four main types of vaccines: Live-attenuated vaccines, Inactivated Vaccines, Recombinant/Conjugate/Subunit Vaccines, and Toxoid Vaccines. Vaccines have a long history with continuously evolving premium and new generation vaccines. The vaccine market can be segmented on the basis of disease, type, route of administration, patient type, and end-users.
The global vaccine market has increased at a significant CAGR during the years 2015-2019 and projections are made that the market would rise in the next four years i.e. 2020-2024 tremendously. The vaccine market is expected to increase due to increasing prevalence of infectious diseases, rising focus on immunization, growing population, escalating healthcare spending, a surge in the use of adjuvants, rising initiatives by the government and non-government organizations, etc. Yet the market faces some challenges such as inadequate access to vaccines, stringent regulations, etc.
Companies Mentioned
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A. (Sanofi Pasteur)
